iRemedy Healthcare
PrivateLast Round
Crowdfunding
Oct 1, 2023
Total Funding Raised
$8.28M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
iRemedy Healthcare operates in Healthcare & Life Sciences and is based in Stuart, Florida. Its latest recorded funding round was a Crowdfunding round in October 2023.
iRemedy Healthcare is a healthcare technology company that operates an AI-powered e-commerce marketplace to modernize and streamline the global medical supply chain for healthcare providers, government agencies, and consumers.
Sector
Healthcare & Life Sciences
Verticals
E-commerce, Supply Chain, Medical Devices, Pharma Supply Chain, Healthcare Analytics
Business Model
B2B
Customer Profile
Marketplace Commission, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iRemedy Healthcare Comparables
Compare iRemedy Healthcare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bttn | 89% | |
| OpenMarkets Health | 74% | |
| Medikabazaar | 70% |
For institutional investors. Book with your work email.
iRemedy Healthcare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Oct 1, 2023 | ||||
| Crowdfunding | Jun 30, 2023 | ||||
| Private Placement | Feb 13, 2022 | ||||
| Debt | May 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 298% MoM, reaching 2.6K.
- Apr 8, 2026
Job posting indicates the company is publicly traded.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 27, 2026
iRemedy Healthcare Companies, Inc. appoints General Perna to its advisory bench as it expands work reshoring U.S. medical manufacturing and supports federal engagements on supply chain resiliency.
- hiresAug 27, 2026
iRemedy Healthcare Companies, Inc. appoints retired four-star General Gustave F. Perna to its Strategic Advisory Board on Aug 27th '26 in Florida, adding his military logistics and healthcare supply-chain leadership.
For institutional investors. Book with your work email.
iRemedy Healthcare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about iRemedy Healthcare's valuation, stock price, and market status.
Is iRemedy Healthcare a public or private company?
iRemedy Healthcare is a private company.
What is the current stock price of iRemedy Healthcare?
iRemedy Healthcare is a private company, so its shares have no public market price. Caplight tracks iRemedy Healthcare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is iRemedy Healthcare worth (valuation)?
Valuation information for iRemedy Healthcare is not publicly available.
Can I buy iRemedy Healthcare stock?
iRemedy Healthcare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was iRemedy Healthcare's last funding round?
iRemedy Healthcare's most recent funding round was Crowdfunding on October 1, 2023.
Who are the main investors in iRemedy Healthcare?
Investor information for iRemedy Healthcare is not publicly disclosed.
Will iRemedy Healthcare IPO soon?
No public IPO plans have been announced for iRemedy Healthcare.
How can I track iRemedy Healthcare secondary market activity?
Caplight tracks bids, offers, and trades in iRemedy Healthcare's shares on secondary markets.